Monica P Shah
Overview
Explore the profile of Monica P Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah M, Morgan C, Beeson J, Peach E, Davis J, McPake B, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39771975
: The integration of maternal and child health services (MCH) with routine immunization is an important global health strategy, particularly in low- and middle-income countries (LMICs). However, evidence is lacking...
2.
Woyessa A, Shah M, Azmeraye B, Pan J, Lisanwork L, Yimer G, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066400
Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced...
3.
Muhoza P, Shah M, Amponsa-Achiano K, Gao H, Quaye P, Opare W, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066354
Strengthening routine immunization systems to successfully deliver childhood vaccines during the second year of life (2YL) is critical for vaccine-preventable disease control. In Ghana, the 18-month visit provides opportunities to...
4.
Solomon K, Aksnes B, Woyessa A, Geri C, Sadi C, Matanock A, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066340
Ethiopia introduced a second dose of measles-containing vaccine (MCV2) in 2019 to provide further protection against measles and further progress toward elimination. However, the sub-optimal coverage of both MCV1 and...
5.
Schneider Z, Busbee A, Boily M, Shah M, Hwang J, Lindblade K, et al.
Am J Trop Med Hyg
. 2024 Jan;
110(4_Suppl):30-37.
PMID: 38266300
In designing mass drug administration (MDA) campaigns, it is imperative to consider contextual factors that affect uptake of the intervention, including acceptability, cost, feasibility, and health system considerations, to ensure...
6.
Schneider Z, Shah M, Boily M, Busbee A, Hwang J, Lindblade K, et al.
Am J Trop Med Hyg
. 2023 Dec;
110(4_Suppl):17-29.
PMID: 38118174
Malaria remains a significant cause of morbidity and mortality, even in low-transmission settings. With the advent of longer acting, more effective, and well-tolerated antimalarials, there is renewed interest in the...
7.
Shah M, Westercamp N, Lindblade K, Hwang J
Am J Trop Med Hyg
. 2023 Dec;
110(4_Suppl):38-43.
PMID: 38118171
Several temperate countries have used mass chemoprevention interventions with medicines of the 8-aminoquinoline class that prevent relapses from Plasmodium vivax before peak transmission to reduce transmission of malaria. The WHO...
8.
Tusell M, Steinhardt L, Gutman J, Schneider Z, Bhamani B, Shah M, et al.
Am J Trop Med Hyg
. 2023 Dec;
110(4_Suppl):11-16.
PMID: 38118164
The basis for an evidence-based recommendation is a well-conducted systematic review that synthesizes the primary literature relevant to the policy or program question of interest. In 2020, the WHO commissioned...
9.
Muhoza P, Shah M, Gao H, Amponsa-Achiano K, Quaye P, Opare W, et al.
Vaccines (Basel)
. 2023 Oct;
11(10).
PMID: 37896919
Background: Understanding the drivers of coverage for vaccines offered in the second year of life (2YL) is a critical focus area for Ghana's life course approach to vaccination. This study...
10.
Shah M, Chebore W, Lyles R, Otieno K, Zhou Z, Plucinski M, et al.
Malar J
. 2022 Nov;
21(1):319.
PMID: 36336700
Background: Detection of malaria parasitaemia in samples that are negative by rapid diagnostic tests (RDTs) requires resource-intensive molecular tools. While pooled testing using a two-step strategy provides a cost-saving alternative...